Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Recs

0
Player Avatar nveagle (37.17) Submitted: 1/31/2012 12:03:54 PM : Outperform Start Price: $38.56 LLY Score: +5.69

Nice steady dividend.

Featured Broker Partners


Advertisement